MicroStrategy
MSTR
Tesla
TSLA
MARA Holdings
MARA
Coinbase
COIN
Amazon
AMZN
US Stock MarketDetailed Quotes
BTAI BioXcel Therapeutics
- 0.351
- +0.005+1.36%
Close Dec 24 13:00 ET
- 0.351
- 0.0000.00%
Post 17:01 ET
16.98MMarket Cap-0.17P/E (TTM)
0.357High0.327Low419.98KVolume0.340Open0.346Pre Close142.66KTurnover1.04%Turnover RatioLossP/E (Static)48.35MShares4.17052wk High-0.20P/B14.12MFloat Cap0.30052wk Low--Dividend TTM40.21MShs Float71.500Historical High--Div YieldTTM8.75%Amplitude0.300Historical Low0.339Avg Price1Lot Size
About BioXcel Therapeutics Company
BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of artificial intelligence solutions in neuroscience and immuno-oncology. It also focuses on utilizing technology and research to develop therapeutics solutions. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT.
Company Profile
SymbolBTAI
Company NameBioXcel Therapeutics
Listing DateMar 8, 2018
Issue Price11.00
Founded2017
CEODr. Vimal Mehta, PhD
MarketNASDAQ
Employees74
Fiscal Year Ends12-31
Address555 Long Wharf Drive,12th floor
CityNew Haven
ProvinceConnecticut
CountryUnited States of America
Zip Code06511
Phone1-475-238-6837
Company Executives
- Name
- Position
- Salary
- Dr. Vimal Mehta, PhD
- Director, Chief Executive Officer and President
- 4.73M
- Dr. Frank D. Yocca, PhD
- Senior Vice President and Chief Scientific Officer
- --
- Richard I. Steinhart
- Senior Vice President, Chief Financial Officer and Principal Accounting Officer
- --
- Javier Rodriguez
- Senior Vice President, Chief Legal Officer and Corporate Secretary
- 1.12M
- Dr. Vincent J. O'Neill, M.D.
- Executive Vice President, Chief of Product Development and Chief Medical Officer
- --
- Dr. Peter Mueller,PhD
- Chairman of the Board
- 367.33K
- Dr. Michal Votruba, M.D.,PhD
- Independent Director
- 307.33K
- Dr. Sandeep Laumas, M.D.
- Independent Director
- 329.83K
- June Bray
- Independent Director
- 327.33K
- Michael Miller
- Independent Director
- 332.33K
- David J. Mack
- Independent Director
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.